Traumatic brain injuries assessment market growth is a significant public health issue in India. They contribute to the demise, harm, and disabling of young, active members of society. India suffers huge economic losses due to TBIs, yet they are unquantifiable. TBIs will rise in India as it moves toward greater growth and development in terms of motorization and urbanization. The World Health Organization's recent world reports on road traffic injury prevention and violence &health make clear how serious the problem of injuries is getting around the world and how urgently programs for prevention, management, and rehabilitation need to be designed and evaluated. India is one nation that has not prioritized prevention.
TBIs negatively affect executive function and self-control. The ability to control stress- and anxiety-related behavior is known as self-regulation. For someone with a TBI, this can involve difficulty settling down, difficulty waiting their turn, or having overpowering emotions in strange settings. Executive functioning refers to higher-order brain functions that are involved in planning, recalling, setting goals, focusing attention, and obeying directions. TBI sufferers may easily become disoriented or forget things, and they may find it challenging to learn new information, complete paperwork, or use public transportation.
The adoption of the most recent technologies and the launch of new products by market participants are expected to accelerate market expansion during the forecast period. For instance, Bio Direction, Inc.’s NanoDx system is a quick point-of-care (POC) diagnostic that accurately diagnoses concussions/TBIs in under two minutes.
The study, which is being funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), is still in progress, but preliminary findings indicate that the pandemic has a significant impact on those who have had brain injuries, including social isolation, disruption of daily life, and effects on cognition. The Administration for Community Living-funded Traumatic Brain Damage Technical Assistance and Resource Center (TBI TARC) set out to further study how COVID-19 has affected people with brain injuries. The TBI Advisory and Leadership (TAL) group's five members were questioned by the TBI TARC. The TAL group's goal is to direct TBI TARC's priorities.
The key players profiled in this report include Integra Lifesciences, BioDirection, Inc., Nihon Kohden Corp., Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Zagros Petrochemical Co., Koninklijke Philips N.V, Boston Scientific Corporation, and Elekta.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the traumatic brain injuries assessment market analysis from 2021 to 2031 to identify the prevailing traumatic brain injuries assessment market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the traumatic brain injuries assessment market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global traumatic brain injuries assessment market trends, key players, market segments, application areas, and market growth Strategies.
Key Market Segments
By End-user- Hospital
- Diagnostics Center
By Diagnostic Type
- CT-Scan
- MRI
- Intracranial Pressure Monitoring
- Partial Pressure of Oxygen in Brain Tissue (pBrO2)
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- UAE
- South Africa
- Rest of LAMEA
Key Market Players
- brainscope company inc.
- NOVASIGNAL CORPORATION
- Integra LifeSciences Holdings Corporation
- Natus Medical Incorporated
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- BioDirection, Inc.
- Nihon Kohden Corp.
- RAUMEDIC AG
- Compumedics Ltd.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
Executive Summary
According to the report titled, 'Traumatic brain injuries assessment Market,' the traumatic brain injuries assessment market was valued at $9.6 billion in 2021, and is estimated to reach $18.4 billion by 2031, growing at a CAGR of 7% from 2022 to 2031.Traumatic brain injury is defined as ''a change in brain function, or other signs of brain pathology, produced by an external force.’’ It happens when an outside force strikes the brain and is frequently brought on by a blow, bump, jolt, or piercing head wound. However, not all strikes or jolts to the head result in traumatic brain injury; some only harm the skull's bony structure without harming the brain.
Rising cases of traumatic brain injuries among people, globally, owing to various factors like brain injury, accident, trauma, depression, and stress is expected to drive the market of traumatic brain injuries assessment market in the coming years. The number of drugs being developed for the treatment of traumatic brain injury (TBI) is increasing significantly as a result of the condition's increased incidence. Many drugs in the clinical trials of development are expected to receive marketing approval within the forecast period. Traumatic brain injuries are an important public health concern that cause a sizeable number of cases each year all over the world. For instance, approximately 3.5 million Americans currently suffer from a persistent handicap brought on by a traumatic brain injury, according to the CDC. Most of these cases are a result of accidents. As a result, it is anticipated that rising numbers of traffic accidents and injuries will increase the need for TBI assessment and management tools.
The market also offers growth opportunities to the key players in the market. An increase in patients' preferences for minimally invasive neurosurgeries is anticipated to fuel traumatic brain injuries assessment market expansion. Currently, minimally invasive techniques can be used to treat the majority of TBIs, including MRI or CT scans, transcranial Doppler ultrasound, and endoscopy to remove hematomas or contusions that developed after brain injury. With the aid of such sophisticated tools, neurosurgeons can access deep brain lesions through a pinhole-sized hole in the skull without endangering the nearby tissues.
The traumatic brain injuries assessment market is segmented into end-user, diagnostic type, and region. On the basis of end-user, the hospital and diagnostic center. On the basis of diagnostic type, the market is categorized into CT-Scan, MRI, intracranial pressure monitoring, partial pressure of oxygen in brain tissue (pBrO2), and others. Region wise, the market was analyzed across North America (the U.S., Canada, and Mexico), Europe (UK, Germany, Italy, France, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, United Arab Emirates, South Africa, and rest of LAMEA.
The key players profiled in the study include Integra Lifesciences, Bio Direction, Inc., Nihon Kohden Corp., Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Zagros Petrochemical Co., Koninklijke Philips N.V, Boston Scientific Corporation, and Elekta. On September 2, 2022, Tri-anim Health Services, specialty distributor of respiratory devices, announced that it has established an exclusive partnership to promote and provide the BrainScope device to hospital emergency departments.
Key Market Insights
By end use, the hospitalized segment was the highest revenue contributor to the market. The main causes of the expansion were an increase in inpatient brain surgeries and a rise in the number of TBI patients globally. Furthermore, hospitals have state-of-the-art equipment that is used by skilled neurologists, which is expected to hasten the segment's growth over the projection period.By diagnostic type, the CT scan segment dominated the global market in 2021. The growth of the sub segment is attributed to the high preference of CT scan among healthcare professionals to understand the prevalence of brain disorder in patients.
Based on region, North America was the highest revenue contributor in 2021. The major reason for the fastest growth is due to growing incidences of brain injuries among people due to high cases of accidents.
Companies Mentioned
- brainscope company inc.
- NOVASIGNAL CORPORATION
- Integra LifeSciences Holdings Corporation
- Natus Medical Incorporated
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- BioDirection, Inc.
- Nihon Kohden Corp.
- RAUMEDIC AG
- Compumedics Ltd.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...